SG11202010485VA - Methods for improving frailty and aging - Google Patents
Methods for improving frailty and agingInfo
- Publication number
- SG11202010485VA SG11202010485VA SG11202010485VA SG11202010485VA SG11202010485VA SG 11202010485V A SG11202010485V A SG 11202010485VA SG 11202010485V A SG11202010485V A SG 11202010485VA SG 11202010485V A SG11202010485V A SG 11202010485VA SG 11202010485V A SG11202010485V A SG 11202010485VA
- Authority
- SG
- Singapore
- Prior art keywords
- aging
- methods
- frailty
- improving
- improving frailty
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Toxicology (AREA)
- Physical Education & Sports Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862662028P | 2018-04-24 | 2018-04-24 | |
PCT/US2019/028911 WO2019209949A1 (en) | 2018-04-24 | 2019-04-24 | Methods for improving frailty and aging |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202010485VA true SG11202010485VA (en) | 2020-11-27 |
Family
ID=68295813
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202010485VA SG11202010485VA (en) | 2018-04-24 | 2019-04-24 | Methods for improving frailty and aging |
Country Status (8)
Country | Link |
---|---|
US (1) | US20210236594A1 (en) |
JP (1) | JP2021522271A (en) |
CN (1) | CN112203675A (en) |
AU (1) | AU2019261592A1 (en) |
CA (1) | CA3097989A1 (en) |
EA (1) | EA202092530A1 (en) |
SG (1) | SG11202010485VA (en) |
WO (1) | WO2019209949A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20220273773A1 (en) * | 2019-08-02 | 2022-09-01 | The General Hospital Corporation | Targeting the gastrointestinal barrier to treat age-related disorders |
WO2022093763A1 (en) * | 2020-10-29 | 2022-05-05 | Edifice Health, Inc. | Methods and compositions for diagnosing and treating frailty |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005057218A2 (en) * | 2003-12-02 | 2005-06-23 | Cleveland Clinic Foundation | Methods of identifying modulators of apoptosis from parasites and uses thereof |
JP5285278B2 (en) * | 2004-12-22 | 2013-09-11 | クリーブランド クリニック ファウンデイション | Flagellin related polypeptides and uses thereof |
KR20070095338A (en) * | 2004-12-24 | 2007-09-28 | 가부시끼가이샤 하야시바라 세이부쓰 가가꾸 겐꾸조 | Hepatic function remedial agent |
US20090247476A1 (en) * | 2006-05-15 | 2009-10-01 | Erasmus Mc | Mannitol and/or proline for prevention and treatment of ageing related symptoms |
WO2009102818A1 (en) * | 2008-02-11 | 2009-08-20 | Cleveland Biolabs, Inc. | Method for reducing the effects of chemotheraphy using flagellin related polypeptides |
KR101520336B1 (en) * | 2012-11-30 | 2015-05-14 | 전남대학교산학협력단 | Compositions for prevention, improvement and treatment of Aging Phenotypes Comprising Recombinant Fusion Protein with Vibrio vulnificus Flagellin and Pathogenic Antigen |
JP6940916B2 (en) * | 2014-07-30 | 2021-09-29 | ゲノム プロテクション,インコーポレイテッド | Flagellin composition and use |
EP3206708B1 (en) * | 2014-10-16 | 2022-11-02 | Cleveland Biolabs, Inc. | Methods and compositions for the treatment of radiation-related disorders |
-
2019
- 2019-04-24 JP JP2020560271A patent/JP2021522271A/en active Pending
- 2019-04-24 US US17/049,720 patent/US20210236594A1/en not_active Abandoned
- 2019-04-24 CA CA3097989A patent/CA3097989A1/en active Pending
- 2019-04-24 AU AU2019261592A patent/AU2019261592A1/en not_active Abandoned
- 2019-04-24 CN CN201980035285.3A patent/CN112203675A/en active Pending
- 2019-04-24 WO PCT/US2019/028911 patent/WO2019209949A1/en unknown
- 2019-04-24 EA EA202092530A patent/EA202092530A1/en unknown
- 2019-04-24 SG SG11202010485VA patent/SG11202010485VA/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP3784263A1 (en) | 2021-03-03 |
WO2019209949A1 (en) | 2019-10-31 |
EA202092530A1 (en) | 2021-02-01 |
CN112203675A (en) | 2021-01-08 |
CA3097989A1 (en) | 2019-10-31 |
JP2021522271A (en) | 2021-08-30 |
AU2019261592A1 (en) | 2020-11-19 |
US20210236594A1 (en) | 2021-08-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL281568A (en) | Collagen-localized immunomodulatory molecules and methods thereof | |
SG11202101185QA (en) | Methods and apparatus for harq enhancement | |
EP3633995A4 (en) | Method and device for chroma prediction | |
EP3275255A4 (en) | Methods and apparatus for enhancement for harq with channel repetitions | |
SG10201605928TA (en) | Test wafer and using method therefor | |
SG11202100860YA (en) | Blockchain-based methods and apparatuses for recording structured work | |
IL288370A (en) | Methods and apparatuses for patient-derived micro-organospheres | |
EP3321866A4 (en) | Method and device for assessing cooking quality | |
EP3396369A4 (en) | Crack measurement device and method | |
GB201816911D0 (en) | Apparatus and methods | |
GB201910188D0 (en) | Analyser | |
SG11202010485VA (en) | Methods for improving frailty and aging | |
ZA201804039B (en) | Apparatus and method for aging wine | |
IL279074A (en) | Electrode assembly and method for its preparation | |
EP3752819C0 (en) | Analyzer | |
GB201819508D0 (en) | Non-destructive testing | |
EP3313115A4 (en) | Voice quality evaluation method and device | |
SG11201606083TA (en) | Aging analysis method and aging analysis device | |
GB2588346B (en) | Apparatus and methods | |
GB201913035D0 (en) | Test | |
EP3784263A4 (en) | Methods for improving frailty and aging | |
EP3438788A4 (en) | Cloud-based device and operating method therefor | |
PT3844465T (en) | Pv-device having reduced aging | |
IL276696B1 (en) | Bead-on-tile apparatus and methods | |
GB2606297B (en) | Electrophoresis device |